Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration

Area of Science:

• Oncology
• Gastroenterology
• Molecular Biology

Background:

• Apc is a tumor suppressor gene crucial for intestinal homeostasis.
• Loss of Apc function leads to increased beta-catenin, promoting cell growth and tumor formation.
• Beta-catenin plays a key role in cell-cell adhesion and regulating cellular proliferation.

Purpose of the Study:

• To investigate the effects of a single Apc mutation on intestinal cells.
• To determine if sulindac sulfide can normalize beta-catenin levels and cell migration in Apc-mutant mice.
• To explore the therapeutic potential of sulindac sulfide in Apc-associated intestinal tumorigenesis.

Main Methods:

• Utilized mice with a germ-line Apc mutation (Min/+ model).
• Assessed enterocyte beta-catenin expression in histologically normal intestinal mucosa.
• Quantified enterocyte crypt-villus migration rates.
• Administered sulindac sulfide to Min/+ animals and evaluated its effects.

Main Results:

• Increased enterocyte beta-catenin expression was observed in mice with a single Apc mutation.
• Enterocyte crypt-villus migration was reduced by 25% in these mice.
• Sulindac sulfide treatment normalized both beta-catenin levels and enterocyte migration.
• These alterations occurred even in histologically normal intestinal tissue.

Conclusions:

• Alterations in enterocyte migration occur early, in cells with a single mutant Apc allele.
• Sulindac sulfide demonstrates potential to normalize aberrant enterocyte growth and migration.
• These findings suggest a therapeutic strategy for Apc-associated intestinal diseases.